SK Bioscience releases results from phases 1 and 2 of COVID-19 trial with 99% forming antibodies

SK Bioscience, Astrazeneca and Seoul's health ministry sign letter of intent on COVID-19 vaccine ...Подробнее

SK Bioscience's COVID-19 vaccine granted phase three trial approvalПодробнее

J&J reports positive phase 1/2 Covid-19 vaccine trial resultsПодробнее

COVID-19 vaccine shows positive results in first phase of human trialsПодробнее

Health authorities will decide whether to approve S. Korea's first COVID-19 vaccine candidate ...Подробнее

Pres. Moon visits SK Bioscience to encourage COVID-19 vaccine researchersПодробнее

SK Bioscience to conduct phase 3 clinical trial of its COVID-19 vaccine candidateПодробнее

[Bio NEWS] SK Bioscience applies for phase III clinical trial for COVID-19 vaccine booster shotsПодробнее

[Bio NEWS] SK Bioscience to apply for MFDS approval for a COVID-19 vaccineПодробнее

Covid-19 antibodies last six months after infection, study findsПодробнее

S. Korea's first domestic COVID-19 vaccine approved by Ministry of Food and Drug SafetyПодробнее

J&J COVID-19 Vaccine: 99% of Participants Developed Neutralizing AntibodiesПодробнее

DOMESTIC VACCINE GOES INTO 3RD CLINICAL TRIAL (News Today) l KBS WORLD TV 210811Подробнее

Yoon visits S. Korean COVID-19 vaccine maker SK BioscienceПодробнее

COVID-19 Pandemic Update 101: T Cell Immunity vs. Antibodies & Prior Exposure to Other CoronavirusesПодробнее

Novavax starts Phase 1 clinical trial of coronavirus vaccine candidateПодробнее

Phase I Clinical Trials Underway For CoVID-19 Vaccine (What Does This Mean?)Подробнее

AstraZeneca Phase I COVID-19 Clinical Trial InitiatedПодробнее

The First Covid Vaccines May Not Prevent Covid InfectionПодробнее